Search research articles
Contact Us
Filters
Showing results (211-220 of 306) with videos related to
Page
of 31
Sort By:
Epilepsia
|
August 11, 2022
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): II. Drugs in more advanced clinical development
Meir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia
|
November 9, 2020
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development
Meir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia
|
August 10, 2022
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia
|
February 16, 2011
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy
Cinzia Fattore, Clementina Boniver, Giuseppe Capovilla, et al.
Neurology
|
July 19, 2015
Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP
Torbjörn Tomson, Dina Battino, Erminio Bonizzoni, et al.
Epilepsia
|
April 30, 2009
Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine
Erik Saetre, Mikael Abdelnoor, Jan Peder Amlie, et al.
Epilepsy & Behavior : E&B
|
September 1, 2024
Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol
Susanna Stjerna, Yfke Huber-Mollema, Torbjörn Tomson, et al.
Epilepsia
|
July 20, 2007
Vigabatrin and epilepsy: lessons learned
John M Wild, Hyo-sook Ahn, Michel Baulac, et al.
Epilepsia
|
May 29, 2018
No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk-An analysis of Finnish health register and German health insurance data
Christoph Helmstaedter, Ettore Beghi, Christian E Elger, et al.
Epilepsy & Behavior : E&B
|
October 16, 2024
Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol"
Susanna Stjerna, Yfke Huber-Mollema, Torbjörn Tomson, et al.
Page
of 31
Search research articles
Search
Showing results (211-220 of 306) with videos related to
Sort By:
Page
of 31
Epilepsia
|
August 11, 2022
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): II. Drugs in more advanced clinical development
Meir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia
|
November 9, 2020
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development
Meir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia
|
August 10, 2022
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia
|
February 16, 2011
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy
Cinzia Fattore, Clementina Boniver, Giuseppe Capovilla, et al.
Neurology
|
July 19, 2015
Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP
Torbjörn Tomson, Dina Battino, Erminio Bonizzoni, et al.
Epilepsia
|
April 30, 2009
Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine
Erik Saetre, Mikael Abdelnoor, Jan Peder Amlie, et al.
Epilepsy & Behavior : E&B
|
September 1, 2024
Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol
Susanna Stjerna, Yfke Huber-Mollema, Torbjörn Tomson, et al.
Epilepsia
|
July 20, 2007
Vigabatrin and epilepsy: lessons learned
John M Wild, Hyo-sook Ahn, Michel Baulac, et al.
Epilepsia
|
May 29, 2018
No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk-An analysis of Finnish health register and German health insurance data
Christoph Helmstaedter, Ettore Beghi, Christian E Elger, et al.
Epilepsy & Behavior : E&B
|
October 16, 2024
Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol"
Susanna Stjerna, Yfke Huber-Mollema, Torbjörn Tomson, et al.
Page
of 31